ENTITY
Becton Dickinson and Co

Becton Dickinson and Co (BDX US)

58
Analysis
Health Care • United States
Becton, Dickinson and Company is a global medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
more
bullish•GCI Liberty Class C
•21 Jul 2025 10:33

Weekly Update (GLIBK, BDX, WAT)

The big news this week is Liberty’s spin-off GCI Liberty began trading. On July 14, 2025, Becton Dickinson (BDX) announced a tax-free Reverse...

Logo
413 Views
Share
•22 May 2023 16:36

The Innovations Portfolios - Week Twenty Six

The small-Cap (+4.1%) and midcap (+1.9%) portfolios continues to outperform respective benchmarks, but the willful omission of mega-tech names has...

Logo
347 Views
Share
•17 Apr 2023 21:34

The Innovations Portfolios - Week Twenty One

For the twenty-one weeks since inception ended 14 April the innovation small cap portfolio was up 5.9%, mid cap portfolio was up 4.4% and the large...

Logo
380 Views
Share
•03 Apr 2023 09:25

The Innovations Portfolios - Week Nineteen

For the nineteen since inception ended 31 March the innovation small cap portfolio was up 8.0%, the innovation mid cap portfolio was up 3.2% and...

Logo
427 Views
Share
•23 Jan 2023 08:04

The Innovations Portfolio - Week Nine

For the nine weeks since inception ended 20 Jan the combined innovation portfolio was +3.5%, versus DJIA -1.1%, S&P500 +0.2%, Nasdaq -0.1%,...

Logo
475 Views
Share
x